Has the use of concomitant cardiac medications improved over time in primary prevention ICD patients? Insights from the APPRAISE ATP study

Back

ESC Professional Premium Access

Has the use of concomitant cardiac medications improved over time in primary prevention ICD patients? Insights from the APPRAISE ATP study

Session: Implantable/wearable devices and sudden cardiac death

Topic: Cardioversion and Defibrillation

Speaker: Professor L. Mont (Barcelona, ES)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Lluis Mont

Hospital Clinic, University of Barcelona, Barcelona (Spain)

30 presentations

3 followers

6 more presentations in this session

Changes in study enrollment of patients with non-ischemic cardiomyopathy receiving an ICD for primary prevention: Insights from the APPRAISE ATP study

Speaker: Professor L. Mont (Barcelona, ES)

Access

Abstract

Slides

Autopsy findings and cardiac arrest rhythms in young obese patients with sudden cardiac death of uncertain etiology

Speaker: Doctor V. Goel (Melbourne, AU)

Wearable cardioverter defibrillator after ICD-system explantation: data from a multicenter registry

Speaker: Mrs K. Koepsel (Bochum, DE)

Long-term stability of atrial sensing in implantable cardioverter-defibrillators with floating atrial dipole leads

Speaker: Doctor I. Ferreira Neves (Lisboa, PT)

Cardiac resynchronization therapy with or without defibrillation in patients with non-ischemic cardiomyopathy: a systematic review and meta-analysis

Speaker: Doctor V. Devesa Neto (Viseu, PT)

Access the full session

Implantable/wearable devices and sudden cardiac death

Speakers: Professor L. Mont, Professor L. Mont, Doctor V. Goel, Mrs K. Koepsel, Doctor I. Ferreira Neves...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources